CF Network

The RCPAQAP are delighted to be partnered with the CF Network for the provision of their External Quality Assessment (EQA) for Cystic Fibrosis (CF) for Australia and New Zealand Laboratories. 

The aim of the CF EQA scheme is to evaluate the entire analytical process, from DNA sample receipt and genotyping up to the written report (examples) with the final interpretation of the data as it is normally being sent to the clinician who requested for the genetic test.

As a result of this partnership, customers are now able to enrol in Cystic Fibrosis EQA through the RCPAQAP customer portal, myQAP. This offers the following advantages:

  • The convenience of being able to enrol in both company’s programs via our customer portal, myQAP
  • A reduction in importation fees for Australasian laboratories

For more information on the CF Network please visit their website:

For all general enquiries, please contact the CF Network directly at


Cystic Fibrosis

This is an external quality assessment scheme for cystic fibrosis provided by the European Cystic Fibrosis Network (CF Network). Purified DNA samples accompanied by mock clinical cases will be provided to registered laboratories to test for the presence of CFTR variants using routine protocols. Laboratories are required to submit written reports and raw data via eletronic upload to the CF Network website.

Frequency / Number of samples

1 survey / 3 samples per survey (DNA in TE buffer)


Molecular genetic analysis; variant screening of the CFTR gene

Product details last updated on August 13, 2019